Health Care & Life Sciences » Biotechnology | Response Genetics Inc.

Response Genetics Inc.

Response Genetics Inc.
Stock Exchange Other OTC
EPS
-
Market Cap
$54.31 K
Shares Outstanding
38.8 M
Public Float
-

Profile

Address
1640 Marengo Street
Los Angeles California 90033
United States
Employees -
Website http://www.responsegenetics.com
Updated 07/08/2019
Response Genetics, Inc. engages in the research and development of clinical diagnostic tests for cancer. Its platforms include analysis of single biomarkers using the polymerase chain reaction method as well as global gene interrogation using microarray methods from paraffin or frozen tissue specimens. It also provides pharmacogenomic testing services of clinical trial specimens to pharmaceutical companies.

Financials

View All
Created with Highcharts 5.0.14Response Genetics Inc.Net Income. Fiscal year is January-December. All values USD Thousands.4 6704 6705 7025 7027 7577 7578 0208 02013 69913 6992010201120122013201402.5k5k7.5k10k12.5k15k
Created with Highcharts 5.0.14Response Genetics Inc.Sales/Revenue. Fiscal year is January-December. All values USD Thousands.21 27721 27722 64222 64218 73618 73619 80119 80116 72016 7202010201120122013201405k10k15k20k25k

Kevin Roy Harris
Chief Financial Officer, Director & Vice President
Kevin Roy Harris
Chief Financial Officer, Director & Vice President